Health

Source link : https://newshealth.biz/health-news/hydroxyurea-and-pregnancy-safety-data-provide-reassurance/ No maternal deaths and no hydroxyurea-related teratogenic malformations occurred following hydroxyurea exposure during pregnancy in more than 200 patients with sickle cell disease. Medscape Medical News Source link : https://www.medscape.com/viewarticle/hydroxyurea-and-pregnancy-safety-data-provide-reassurance-2025a1000y88?src=rss Author : Publish date : 2025-12-07 22:25:00 Copyright for syndicated content belongs to the linked Source. The post Hydroxyurea and Pregnancy: Safety Data Provide Reassurance first […] More

Source link : https://newshealth.biz/health-news/chemotherapy-free-triplet-sets-a-new-benchmark-in-follicular-lymphoma/ (MedPage Today) — ORLANDO — Adding the bispecific antibody epcoritamab (Epkinly) to a standard chemotherapy-free regimen for relapsed or refractory follicular lymphoma improved responses and reduced the risk of disease progression or death… Source link : https://www.medpagetoday.com/meetingcoverage/ashhematology/118878 Author : Publish date : 2025-12-07 21:18:00 Copyright for syndicated content belongs to the linked Source. The post Chemotherapy-Free […] More

Source link : https://newshealth.biz/health-news/this-would-be-a-hugely-important-finding-what-we-heard-this-week/ (MedPage Today) — “If the shingles vaccine really prevents or delays dementia … this would be a hugely important finding for clinical medicine, population health, and research into the causes of dementia.” — Pascal Geldsetzer, MD, PhD, of… Source link : https://www.medpagetoday.com/opinion/what-we-heard/118867 Author : Publish date : 2025-12-07 21:00:00 Copyright for syndicated content belongs to […] […] More

Source link : https://newshealth.biz/health-news/sickle-cell-pain-management-in-the-ed-remains-suboptimal/ Less than a third of ED visits for acute sickle cell disease pain were guideline-adherent for the timely administration of the first dose of opioid pain medication. Medscape Medical News Source link : https://www.medscape.com/viewarticle/sickle-cell-pain-management-ed-remains-suboptimal-2025a1000y87?src=rss Author : Publish date : 2025-12-07 21:21:00 Copyright for syndicated content belongs to the linked Source. The post Sickle Cell Pain Management […] More

Source link : https://newshealth.biz/health-news/tbi-free-conditioning-before-transplant-effective-in-mrd-negative-b-all/ (MedPage Today) — ORLANDO — A conditioning regimen free from total body irradiation (TBI) appeared to be just as effective as standard of care (SoC) in a common type of childhood leukemia, according to a phase II study. The EndRad trial evaluated… Source link : https://www.medpagetoday.com/meetingcoverage/ashhematology/118875 Author : Publish date : 2025-12-07 18:12:00 Copyright for […] […] More

Source link : https://newshealth.biz/health-news/alzheimers-benefits-may-continue-after-donanemab-treatment-ends-data-suggest/ (MedPage Today) — New data suggested that donanemab (Kisunla) sustained long-term benefits after a limited dosing period in a subgroup of people with early symptomatic Alzheimer’s disease. Early Alzheimer’s patients who completed their course… Source link : https://www.medpagetoday.com/meetingcoverage/ctad/118877 Author : Publish date : 2025-12-07 19:18:00 Copyright for syndicated content belongs to the linked Source. The post […] More

Source link : https://newshealth.biz/health-news/potential-game-changing-impact-on-mismatched-unrelated-blood-cell-transplantation/ (MedPage Today) — ORLANDO — Stem-cell transplants with mismatched unrelated donors (MMUDs) beyond a single HLA locus ( The post Potential Game-Changing Impact on Mismatched Unrelated Blood Cell Transplantation first appeared on News Health. —- Author : News Health Publish date : 2025-12-07 18:44:00 Copyright for syndicated content belongs to the linked Source. —- 1 – […] More

Source link : https://newshealth.biz/health-news/hematocrit-phlebotomy-benefits-seen-with-rusfertide-in-pv/ No new safety concerns emerged in the 20-week extension of the phase 3 VERIFY study. Medscape Medical News Source link : https://www.medscape.com/viewarticle/hematocrit-phlebotomy-benefits-seen-rusfertide-pv-2025a1000y84?src=rss Author : Publish date : 2025-12-07 19:08:00 Copyright for syndicated content belongs to the linked Source. The post Hematocrit, Phlebotomy Benefits Seen With Rusfertide in PV first appeared on News Health. —- Author : […] More

Source link : https://newshealth.biz/health-news/aml-clinical-data-confirms-lower-survival-in-black-patients/ Cytogenetic risk doesn’t seem to explain the disparity in mortality of Black vs White patients, a study across 10 clinical trials suggests. Medscape Medical News Source link : https://www.medscape.com/viewarticle/aml-clinical-data-confirms-lower-survival-black-patients-2025a1000y86?src=rss Author : Publish date : 2025-12-07 17:44:00 Copyright for syndicated content belongs to the linked Source. The post AML: Clinical Data Confirms Lower Survival in Black Patients […] More

Source link : https://newshealth.biz/health-news/the-internets-risky-pseudo-cures/ (MedPage Today) — In my last emergency medicine rotation, I (Bhaskar) met a patient with a rash. Jane*, whom I met in triage room 12, explained to me in a shaky voice why she had come to the emergency department, rather than going to dinner with… Source link : https://www.medpagetoday.com/opinion/second-opinions/118856 Author : Publish date : […] […] More

Source link : https://newshealth.biz/health-news/fixed-duration-or-continuous-therapy-in-cll-trial-says-take-your-pick/ (MedPage Today) — ORLANDO — A year of combination therapy for previously untreated chronic lymphocytic leukemia (CLL) patients led to similar outcomes compared with indefinite BTK inhibition with ibrutinib (Imbruvica) alone, an interim analysis… Source link : https://www.medpagetoday.com/meetingcoverage/ashhematology/118873 Author : Publish date : 2025-12-07 13:22:00 Copyright for syndicated content belongs to the linked Source. The post […] More

Source link : https://newshealth.biz/health-news/want-good-info-on-epilepsy-treatment-dont-ask-dr-tiktok/ (MedPage Today) — ATLANTA — Much of the content on social media regarding epilepsy treatment isn’t accurate and could actually hurt people, researchers reported at the American Epilepsy Society (AES) annual meeting. In one study analyzing… Source link : https://www.medpagetoday.com/meetingcoverage/aes/118874 Author : Publish date : 2025-12-07 13:42:00 Copyright for syndicated content belongs to the linked […] […] More